Home » Topics » Conferences

Conferences
RSS

Parke-Davis SAR studies lead to potent, selective D4 antagonist

April 28, 1997

Potent TNF inhibitor described by Celgene

April 28, 1997

Potential new treatments highlighted at recent periodontology symposium

April 28, 1997

Potent, metabolically stable cyclic urea HIV protease inhibitors under development at DuPont Merck

April 28, 1997

Glaxo Wellcome discovers potent BAT inhibitor

April 28, 1997

Potent, selective beta3-agonist from Merck & Co.

April 25, 1997

Amino-ketones from Roche found to lower cholesterol levels in animals

April 25, 1997

Novel marine antioxidant described by UNC researchers

April 25, 1997

Lilly prepares water-soluble echinocandin antifungal agents

April 25, 1997

Antiarthritic activity and mechanism of action of mercaptoethylguanidine

April 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...